Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
Chin‐Hsien Lin, Chieh‐Chang Chen, Han‐Lin Chiang, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 367

Showing 1-25 of 367 citing articles:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 789
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Patrice D. Cani, Clara Depommier, Muriel Derrien, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 625-637
Closed Access | Times Cited: 618
Cytokines: From Clinical Significance to Quantification
Chao Liu, Dewei Chu, Kourosh Kalantar‐zadeh, et al.
Advanced Science (2021) Vol. 8, Iss. 15
Open Access | Times Cited: 596
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano, George M. Savva, Janis R. Bedarf, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 493
Parkinson disease and the immune system — associations, mechanisms and therapeutics
Eng‐King Tan, Yinxia Chao, Andrew B. West, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 6, pp. 303-318
Closed Access | Times Cited: 361
Tryptophan Metabolism and Gut-Brain Homeostasis
William Roth, Kimia Zadeh, Rushi Vekariya, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2973-2973
Open Access | Times Cited: 313
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
Velma T. E. Aho, Madelyn C. Houser, Pedro A. B. Pereira, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 310
Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract
Bolun Zhou, Yutong Yuan, Shan Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 269
Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions
Suganya Kanmani, Byung‐Soo Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7551-7551
Open Access | Times Cited: 241
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Zachary D. Wallen, Mary Appah, Marissa Dean, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 189
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, К. Ray Chaudhuri, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2571-2593
Open Access | Times Cited: 187
Biodegradation and disintegration of expanded polystyrene by land snails Achatina fulica
Yang Song, Rongliang Qiu, Jiani Hu, et al.
The Science of The Total Environment (2020) Vol. 746, pp. 141289-141289
Closed Access | Times Cited: 183
Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease
Szu‐Ju Chen, Chieh‐Chang Chen, Hsin-Yu Liao, et al.
Neurology (2022) Vol. 98, Iss. 8
Open Access | Times Cited: 168
Biomarker of Neuroinflammation in Parkinson’s Disease
Tsai-Wei Liu, Chiung‐Mei Chen, Kuo‐Hsuan Chang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4148-4148
Open Access | Times Cited: 126
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Emily Klann, Upuli Dissanayake, Anjela Gurrala, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 121
The human symbiont Mucispirillum schaedleri: causality in health and disease
Simone Herp, Abilash Chakravarthy Durai Raj, Marta Salvado Silva, et al.
Medical Microbiology and Immunology (2021) Vol. 210, Iss. 4, pp. 173-179
Open Access | Times Cited: 112
Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease
Simon Spichak, Thomaz F. S. Bastiaanssen, Kirsten Berding, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 698-761
Open Access | Times Cited: 107
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Manlian Zhu, Xia Liu, Yiru Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 107
Gut bacterial profiles in Parkinson's disease: A systematic review
Zhe Li, Hongfeng Liang, Yingyu Hu, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 29, Iss. 1, pp. 140-157
Open Access | Times Cited: 106
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 85
Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review
Rebecca J. Solch, Julia O. Aigbogun, Andrew G. Voyiadjis, et al.
Journal of the Neurological Sciences (2022) Vol. 434, pp. 120166-120166
Open Access | Times Cited: 78
Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives
Bei Huang, Steven Wai Ho Chau, Yaping Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 77
Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan
Aiym Kaiyrlykyzy, Samat Kozhakhmetov, Dmitriy Babenko, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 75
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 66
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top